Diadenosine polyphosphates directly relax porcine coronary arterial smooth muscle

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 2, 1997, Pages 548-556

  Sumiyoshi, Rieko ^b   Nishimura, Junji ^b   Kawasaki, Junya ^b   Kobayashi, Sei ^b   Takahashi, Shosuke ^a,b   Kanaide, Hideo ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 4 AMINOPYRIDINE; APAMIN; BOVINE SERUM ALBUMIN; CAFFEINE; CALCIUM ION; CHARYBDOTOXIN; CYCLIC AMP; DIADENOSINE PENTAPHOSPHATE; DIADENOSINE TETRAPHOSPHATE; FURA 2; HISTAMINE; POTASSIUM ION; TETRABUTYLAMMONIUM;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY MUSCLE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; CORONARY ARTERY; FLUOROMETRY; MUSCLE FORCE; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION; SWINE; VASODILATATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; CAFFEINE; CALCIUM; CORONARY VESSELS; CYCLIC AMP; CYCLIC GMP; DINUCLEOSIDE PHOSPHATES; HISTAMINE; MUSCLE, SMOOTH, VASCULAR; POTASSIUM CHANNEL BLOCKERS; SWINE; VASODILATION;

EID: 0030729841     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. ABE, S., KANAIDE, H. AND NAKAMURA, M.: Front-surface fluorometry with fura-2 and effects of nitroglycerin on cytosolic calcium concentrations and on tension in the coronary artery of the pig. Br. J. Pharmacol. 101: 545-552, 1990.
2. ABE, S., NISHIMURA, J., NAKAMURA, M. AND KANAIDE, H.: Effects of nicorandil on cytosolic calcium concentrations and on tension development in the rabbit femoral artery. J. Pharmacol. Exp. Ther. 268: 762-771, 1994.
3. BAXI, M. D. AND VISHWANATHA, J. K.: Diadenosine polyphosphates: their biological and pharmacological significance. [Review], J. Pharmacol. Toxicol. Methods 33: 121-128, 1995.
4. 2x-purinoceptors in rat urinary bladder. Br. J. Pharmacol. 112: 1151-1159, 1994.
5. BUSSE, R., OGILVIE, A. AND POHL, U.: Vasomotor activity of diadenosine triphosphate and diadenosine tetraphosphate in isolated arteries. Am. J. Physiol. 254: H828-H832, 1988.
6. 4A. Biochim. Biophys. Acta 1010: 151-159, 1989.
7. DAVIES, G., MACALLISTER, R. J., BOGLE, R. G. AND VALLANCE, P.: Effect of diadenosine phosphates on human umbilical vessels: novel platelet-derived vaso-constrictors. Br. J. Clin. Pharmacol. 40: 170-172, 1995.
8. DELEAN, A., MUNSON, P. J. AND RODBARD, D.: Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol. 235: E97-E102, 1978.
9. 4-tetraphosphate are present and releasable, but metabolically inactive, in human platelets. Biochem. J. 208: 737-742, 1982.
10. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450, 1985.
11. 4A and Other Dinucleoside Polyphosphates, ed. by A. G. McLennan, pp. 81-133, CRC Press, Boca Raton, FL, 1992.
12. 4-tetraphosphate hydrolase is present in human erythrocytes, leukocytes and platelets. Int. J. Biochem. Cell Biol. 27: 201-206, 1995.
13. 4-tetraphosphate. J. Biol. Chem. 266: 6915-6918, 1991.
14. HIRANO, K., KANAIDE, H., ABE, S. AND NAKAMURA, M.: Effects of diltiazem on calcium concentrations in the cytosol and on force of contractions in porcine coronary arterial strips. Br. J. Pharmacol. 101: 273-280, 1990.
15. HOYLE, C. H., POSTORINO, A. AND BURNSTOCK, G.: Pre- and postjunctional effects of diadenosine polyphosphates in the guinea-pig vas deferens. J. Pharm. Pharmacol. 47: 926-931, 1995.
16. 2-purinoceptors in the guinea-pig left atrium by diadenosine polyphosphates. Br. J. Pharmacol. 118: 1294-1300, 1996.
17. KAWASAKI, J., KOBAYASHI, S., MIYAGI, Y., NISHIMURA, J., FUJISHIMA, M. AND KANAIDE, H.: The mechanisms of the relaxation induced by vasoactive intestinal peptide in the porcine coronary artery. Br. J. Pharmacol. 121: 977-985, 1997.
18. KIKUTA, Y., SEKINE, A., TEZUKA, S., OKADA, K., YAMAURA, T. AND NAKAJIMA, H.: Intravenous diadenosine tetraphosphate in dogs. Cardiovascular effects and influence on blood gases. Acta Anaesthesiol. Scand. 38: 284-288, 1994.
19. 3A) in human platelets. Biochem. Biophys. Res. Commun. 115: 253-260, 1983.
20. 4A in human plasma. Purification and characterization of a glycoprotein complex with 5′-nucleotide phosphodiesterase activity. Eur. J. Biochem. 149: 119-127, 1985.
21. 3A in whole blood. The dinucleotides are long-lived signal molecules in the blood ending up as intracellular ATP in the erythrocytes. Eur. J. Biochem. 173: 241-245, 1988.
22. MIYAGI, Y., KOBAYASHI, S., NISHIMURA, J., FUKUI, M. AND KANAIDE, H.: Resting load regulates vascular sensitivity by a cytosolic Ca(2+)-insensitive mechanism. Am. J. Physiol. 268: C1332-C1341, 1995.
23. NAKAE, I., TAKAHASHI, M., TAKAOKA, A., LIU, Q., MATSUMOTO, T., AMANO, M., SEKINE, A., NAKAJIMA, H. AND KINOSHITA, M.: Coronary effects of diadenosine tetraphospate resemble those of adenosine in anesthetized pigs: involvement of ATP-sensitive potassium channels. J. Cardiovasc. Pharmacol. 28: 124-133, 1996.
24. NELSON, M. T. AND QUAYLE, J. M.: Physiological roles and properties of potassium channels in arterial smooth muscle. Am. J. Physiol. 268: C799-C822, 1995.
25. NISHIMURA, J. AND VAN BREEMEN, C.: Direct regulation of smooth muscle contractile elements by second messengers. Biochem. Biophys. Res. Commun. 163: 929-935, 1989.
26. OGILVIE, A., LUTHJE, J., POHL, U. AND BUSSE, R.: Identification and partial characterization of an adenosine (5′) tetraphospho (5′) adenosine hydrolase on intact bovine aortic endothelial cells. Biochem. J. 259: 97-103, 1989.
27. PINTOR, J., DIAZ-REY, M. A., TORRES, M. AND MIRAS-PORTUGAL, M. T.: Presence of diadenosine polyphosphates-Ap4A and Ap5A-in rat brain synaptic terminals. Ca2+ dependent release evoked by 4-aminopyridine and veratridine. Neurosci. Lett. 136: 141-144, 1992.
28. POHL, U., OGILVIE, A., LAMONTAGNE, D. AND BUSSE, R.: Potent effects of AP3A and AP4A on coronary resistance and autacoid release of intact rabbit hearts. Am. J. Physiol. 260: H1692-H1697, 1991.
29. RALEVIC, V., HOYLE, C. H. AND BURNSTOCK, G.: Pivotal role of phosphate chain length in vasoconstrictor versus vasodilator actions of adenine dinucleotides in rat mesenteric arteries. J. Physiol. 483: 703-713, 1995.
30. RODRIGUEZ DEL CASTILLO, A., TORRES, M., DELICADO, E. G. AND MIRAS-PORTUGAL, M. T.: Subcellular distribution studies of diadenosine polyphosphates-Ap4A and Ap5A-in bovine adrenal medulla: presence in chromaffin granules. J. Neurochem. 51: 1696-1703, 1988.
31. SADOSHIMA, J., AKAIKE, N., KANAIDE, H. AND NAKAMURA, M.: Cyclic AMP modulates Ca-activated K channel in cultured smooth muscle cells of rat aortas. Am. J. Physiol. 255: H754-H759, 1988.
32. SCHLUTER, H., OFFERS, E., BRUGGEMANN, G., VAN DER GIET, M., TEPEL, M., NORDHOFF, E., KARAS, M., SPIEKER, C., WITZEL, H. AND ZIDEK, W.: Diadenosine phosphates and the physiological control of blood pressure. Nature 367: 186-188, 1994.
33. SOMLYO, A. V., HAEUSLER, G. AND SOMLYO, A. P.: Cyclic adenosine monophosphate: potassium-dependent action on vascular smooth muscle membrane potential. Science 169: 490-491, 1970.
34. SOMLYO, A. P. AND SOMLYO, A. V.: Signal transduction and regulation in smooth muscle. Nature 372: 231-236, 1994.
35. STONE, T. W. AND PATON, D. M.: Possible subtypes of ATP receptor producing contraction of rat vas deferens, revealed by cross-desensitisation. Gen. Pharmacol. 20: 61-64, 1989.
36. 4-tetraphosphate pyrophosphohydrolase is a member of the MutT family of nucleotide pyrophosphatases. Biochem. J. 311: 717-721, 1995.
37. USHIO-FUKAI, M., ABE, S., KOBAYASHI, S., NISHIMURA, J. AND KANAIDE, H.: Effects of isoprenaline on cytosolic calcium concentrations and on tension in the porcine coronary artery. J. Physiol. 462: 679-696, 1993.
38. 4-tetraphosphate receptor. Biochemistry 32: 3119-3123, 1993.
39. WATANABE, C., YAMAMOTO, H., HIRANO, K., KOBAYASHI, S. AND KANAIDE, H.: Mechanisms of caffeine-induced contraction and relaxation of rat aortic smooth muscle. J. Physiol. 456: 193-213, 1992.
40. 4A) as potential antiplatelet-aggregation agents. Proc. Natl. Acad. Sci. U.S.A. 89: 2370-2373, 1992.